Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG; MRC Cognitive Function, Ageing Neuropathology Study..

Neurology. 2008 Mar 25;70(13):1042-8. doi: 10.1212/01.wnl.0000306697.48738.b6.

PMID:
18362284
2.

Lewy body-related alpha-synucleinopathy in the aged human brain.

Jellinger KA.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35. Epub 2004 Apr 2.

PMID:
15480835
3.

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Jellinger KA.

Acta Neuropathol. 2003 Sep;106(3):191-201. Epub 2003 Jul 5. Erratum in: Acta Neuropathol (Berl). 2003 Dec;106(6):588.

PMID:
12845452
4.

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.

Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA.

Neurology. 2007 Jul 24;69(4):356-9.

PMID:
17646627
5.

Correlations between cortical and subcortical tau pathology.

Attems J, Thomas A, Jellinger K.

Neuropathol Appl Neurobiol. 2012 Oct;38(6):582-90. doi: 10.1111/j.1365-2990.2011.01244.x.

PMID:
22115520
6.

Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.

Uchikado H, Lin WL, DeLucia MW, Dickson DW.

J Neuropathol Exp Neurol. 2006 Jul;65(7):685-97.

PMID:
16825955
7.

Formation and development of Lewy pathology: a critical update.

Jellinger KA.

J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y. Review.

PMID:
19711116
8.

A critical evaluation of the Braak staging scheme for Parkinson's disease.

Burke RE, Dauer WT, Vonsattel JP.

Ann Neurol. 2008 Nov;64(5):485-91. doi: 10.1002/ana.21541.

9.

Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?

Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, DelleDonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE.

Neurobiol Aging. 2011 May;32(5):857-63. doi: 10.1016/j.neurobiolaging.2009.05.019. Epub 2009 Jun 26.

10.

Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly.

Zaccai J, Brayne C, Matthews FE, Ince PG; MRC Cognitive Function and Ageing Neuropathology Study..

Alzheimers Res Ther. 2015 Apr 13;7(1):19. doi: 10.1186/s13195-015-0101-x. eCollection 2015.

11.

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

Jellinger KA.

Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5. Review.

12.

Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ.

Acta Neuropathol. 2016 Mar;131(3):393-409. doi: 10.1007/s00401-015-1526-9. Epub 2015 Dec 31.

13.

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.

Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ.

Mov Disord. 2010 Nov 15;25(15):2508-15. doi: 10.1002/mds.23305.

PMID:
20818670
14.

Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.

Marui W, Iseki E, Nakai T, Miura S, Kato M, Uéda K, Kosaka K.

J Neurol Sci. 2002 Mar 30;195(2):153-9.

PMID:
11897247
15.

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA.

Brain. 2012 Oct;135(Pt 10):3005-14. doi: 10.1093/brain/aws234.

16.

Evidence in favor of Braak staging of Parkinson's disease.

Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y.

Mov Disord. 2010;25 Suppl 1:S78-82. doi: 10.1002/mds.22637.

PMID:
20187227
17.

A critical reappraisal of current staging of Lewy-related pathology in human brain.

Jellinger KA.

Acta Neuropathol. 2008 Jul;116(1):1-16. doi: 10.1007/s00401-008-0406-y. Epub 2008 Jul 1. Review.

PMID:
18592254
18.

Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.

Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW.

Acta Neuropathol. 2008 Jul;116(1):17-24. doi: 10.1007/s00401-008-0383-1. Epub 2008 Apr 30.

19.

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

Neurology. 2005 Mar 8;64(5):834-41.

PMID:
15753419
20.

Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.

Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW.

J Neuropathol Exp Neurol. 2003 Apr;62(4):389-97.

PMID:
12722831

Supplemental Content

Support Center